US 10414732
Polymorphic compounds and uses thereof
granted A61KA61K31/47A61P
Quick answer
US patent 10414732 (Polymorphic compounds and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/47, A61P, A61P27/02